FDA warns duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to assess contamination risk
FDA has issued warning letters to Olympus, FujiFilm and Pentax, for failing to comply with section 522 orders on postmarket surveillance studies for duodenoscopes